Draximage Maa 2.5 mg (Albumin POWDER FOR SOLUTION) 2.5 MG

DRAXIMAGE MAA 2.5 MG is a powder for solution used in medical imaging procedures. This intravenous formulation, containing albumin, is designed for diagnostic purposes. Learn more about its uses and effects.

Strength

2.5 MG

Pack Size

10X10ML

Manufacturer / TM Owner

JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

DRAXIMAGE MAA 2.5 MG is primarily used in medical imaging to enhance the visibility of blood vessels and organs. This diagnostic tool helps healthcare professionals assess blood flow and identify abnormalities. What is DRAXIMAGE MAA used for? It is commonly employed in procedures requiring contrast enhancement, such as angiography.

Side Effects

When administered intravenously, DRAXIMAGE MAA 2.5 MG works by temporarily enhancing the contrast in medical images. This can help in visualizing blood vessels and organs more clearly. Common effects may include temporary discomfort at the injection site, but these are generally mild and short-lived.

Precautions & Warnings

Always handle DRAXIMAGE MAA 2.5 MG with care, following proper medical guidelines. Ensure the solution is prepared correctly and administered by a healthcare professional. Store the powder in a cool, dry place away from direct sunlight.

Avoid Interactions

DRAXIMAGE MAA 2.5 MG may interact with certain medications or substances. It is important to inform your healthcare provider about any other medications you are taking. Avoid mixing with other solutions unless directed by a medical professional.

Frequently Asked Questions

DRAXIMAGE MAA is used in medical imaging to enhance the visibility of blood vessels and organs during diagnostic procedures.

DRAXIMAGE MAA is administered intravenously as a powder for solution, prepared and given by a healthcare professional.

Common effects may include temporary discomfort at the injection site, but these are generally mild and short-lived.

Avoid mixing DRAXIMAGE MAA with other solutions unless directed by a medical professional.

Store the powder in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.